Drug profile

The FDA adverse-event record for Dermaquin

15 FDA reports name Dermaquin, a lower-volume drug in the CVM extract. Species, reactions, and outcomes follow.

#2091 of 2,679
by report volume (all drugs)
15
adverse-event reports
6.7%
death-coded share
Dog
most-reported species
Verify with FDA CVM →

Corpus placement

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Dermaquin ranks #2072 of 2679 by total reports (15). Death-coded-share rank requires at least 50 reports. National dual: Milbemycin Oxime + Spinosad is #1 of 2679 drugs by total adverse-event reports (149,624) at death-coded-share rank 965 of 1130 drugs with at least 50 reports (2.3%); separately, Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) is #1 highest death-coded share at 97.8% (report rank #821).

149,624
Milbemycin Oxime + Spinosad reports (#1)
97.8%
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) death share (#1)
#2072
This drug, reports of 2679

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Dermaquin has 15 reports now versus 14 in that prior snapshot: 1 more (7.1%).

Report change
+1
Death-coded reports
+1
Death-coded share
+6.7 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Dermaquin changes

Signature read: 15 reports place Dermaquin in the lower third of FDA AER volume (#2091 of 2,679).

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
15
Total Reports
1
Deaths Reported
6.7%
Death-coded share of reports

Active Ingredients

Dermaquin

Administration Routes

UnknownOral

Species Affected

Dog 15

Most Affected Breeds

Terrier - Yorkshire 3
Corgi - Welsh Cardigan 2
Collie - Border 2
Shih Tzu 2
Retriever - Labrador 1
Terrier - Rat 1
Hound - Basset 1
Dachshund (unspecified) 1
Crossbred Canine/dog 1
Spaniel - Cocker American 1

Most Reported Reactions

Seizure NOS 6
Lack of efficacy - NOS 5
Pruritus 3
Allergic reaction 3
Alopecia NOS 3
Otitis NOS 3
Gastroenteritis 3
Dermatitis 3
Fungal skin infection NOS 3
Bacterial skin infection NOS 3
Abnormal cytology 3
Intentional misuse 3

Outcome Breakdown

Ongoing
8 (53.3%)
Recovered/Normal
3 (20.0%)
Outcome Unknown
2 (13.3%)
Recovered with Sequela
1 (6.7%)
Died
1 (6.7%)

Dermaquin: lower report volume in the FDA AER row

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

What to do with this drug

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Dermaquin (#2091 of 2,679 by report volume); death-coded 6.7%. PlainBreed drug row · report volume stamp 15 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →